DOI: 10.1210/er.2004-0015. Aromatase Inhibitors in the Treatment of Breast Cancer

Aromatase Inhibitors in the Treatment of Breast Cancer

10.1210/er.2004-0015

Crossref journal-article

The Endocrine Society

Endocrine Reviews (80)

Bibliography

Brueggemeier, R. W., Hackett, J. C., & Diaz-Cruz, E. S. (2005). Aromatase Inhibitors in the Treatment of Breast Cancer. Endocrine Reviews, 26(3), 331â345.

Authors 3

Robert W. Brueggemeier (first)
John C. Hackett (additional)
Edgar S. Diaz-Cruz (additional)

References 166 Referenced 381

{'key': '2019041122335472500_R1', 'year': '2004'} (2004)
{'key': '2019041122335472500_R2', 'first-page': '2053', 'author': 'Weigel', 'year': '2001'} by Weigel (2001)
{'key': '2019041122335472500_R3', 'first-page': '358', 'author': 'Dickson', 'year': '1995'} by Dickson (1995)
{'key': '2019041122335472500_R4', 'first-page': '342', 'article-title': 'Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis.', 'volume': '15', 'author': 'Simpson', 'year': '1994', 'journal-title': 'Endocr Rev'} / Endocr Rev / Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. by Simpson (1994)
10.1016/0039-128X(83)90077-6 / Steroids / Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies. by James (1987)
10.1016/0039-128X(87)90037-7 / Steroids / The importance of local synthesis of estrogen within the breast. by Miller (1987)
10.1002/ijc.2910440208 / Int J Cancer / In situ oestrone synthesis in normal breast and breast tumour tissues: effect of treatment with 4-hydroxyandrostenedione. by Reed (1989)
{'key': '2019041122335472500_R8', 'first-page': '1622', 'article-title': 'A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription.', 'volume': '77', 'author': 'Bulun', 'year': '1993', 'journal-title': 'J Clin Endocrinol Metab'} / J Clin Endocrinol Metab / A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. by Bulun (1993)
10.1016/0960-0760(93)90235-O / J Steroid Biochem Mol Biol / Tissue-specific promoters regulate aromatase cytochrome P450 expression. by Simpson (1993)
10.1016/S0021-9258(18)61364-X / J Biol Chem / Purification and characterization of human placental aromatase cytochrome P-450. by Kellis (1987)
10.1042/bj2010569 / Biochem J / Mechanistic studies on C-19 demethylation in oestrogen biosynthesis. by Akhtar (1982)
10.1002/pro.5560040605 / Protein Sci / A three-dimensional model of aromatase cytochrome P450. by Graham-Lorence (1995)
10.1021/ja044716w / J Am Chem Soc 10.1021/ja044716w / The final catalytic step of cytochrome P450 aromatase: a density functional theory study. by Hackett (2005)
10.1021/cr020443g / Chem Rev / Mechanism of oxidation reactions catalyzed by cytochrome p450 enzymes. by Meunier (2004)
10.1055/s-2004-823022 / Semin Reprod Med / Organization of the human aromatase p450 (CYP19) gene. by Bulun (2004)
10.1006/prep.2001.1464 / Protein Expr Purif / Human aromatase in high yield and purity by perfusion chromatography and its characterization by difference spectroscopy and mass spectrometry. by Gartner (2001)
10.1016/S0960-0760(97)80013-1 / J Steroid Biochem Mol Biol / Transcriptional regulation of CYP19 gene (aromatase) expression in adipose stromal cells in primary culture. by Zhao (1997)
10.1146/annurev.physiol.64.081601.142703 / Annu Rev Physiol / Aromatase—a brief overview. by Simpson (2002)
10.1016/0960-0760(93)90266-Y / J Steroid Biochem Mol Biol / Control of aromatase in breast cancer cells and its importance for tumor growth. by Dowsett (1993)
10.1016/S0960-0760(97)80012-X / J Steroid Biochem Mol Biol / Regulation of aromatase activity within the breast. by Miller (1997)
10.1016/0960-0760(93)90264-W / J Steroid Biochem Mol Biol / Control of aromatase activity in breast cancer cells: the role of cytokines and growth factors. by Reed (1993)
10.1016/S0960-0760(99)00113-2 / J Steroid Biochem Mol Biol / Effects of matrix components on aromatase activity in breast stromal cells in culture. by Quinn (1999)
10.1016/S0960-0760(03)00363-7 / J Steroid Biochem Mol Biol / Validation of new aromatase monoclonal antibodies for immunohistochemistry: progress report. by Sasano (2003)
10.1210/endo.137.12.8940410 / Endocrinology / Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. by Zhao (1996)
10.1002/(SICI)1097-0215(19960904)67:5<684::AID-IJC16>3.0.CO;2-5 / Int J Cancer / Regulation of arachidonic acid metabolism, aromatase activity and growth in human breast cancer cells by interleukin-1β and phorbol ester: dissociation of a mediatory role for prostaglandin E2 in the autocrine control of cell function. by Hughes (1996)
10.1097/00001648-199603000-00017 / Epidemiology / Nonsteroidal antiinflammatory drugs and breast cancer. by Harris (1996)
10.1054/mehy.1998.0009 / Med Hypotheses / Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP19): an extension of the dietary fat hypothesis of breast cancer. by Harris (1999)
10.1053/j.seminoncol.2004.03.042 / Semin Oncol / The role of COX-2 inhibition in breast cancer treatment and prevention. by Arun (2004)
10.1001/jama.291.20.2433 / JAMA / Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. by Terry (2004)
10.1016/S0304-3835(99)00050-6 / Cancer Lett / Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens. by Brueggemeier (1999)
10.1016/S0960-0760(01)00131-5 / J Steroid Biochem Mol Biol / Aromatase and COX-2 expression in human breast cancers. by Brodie (2001)
10.1210/jc.2002-021475 / J Clin Endocrinol Metab / Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes. by Richards (2003)
{'key': '2019041122335472500_R33', 'article-title': 'Translational studies on aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer.', 'author': 'Brueggemeier', 'journal-title': 'J Steroid Biochem Mol Biol, in press'} / J Steroid Biochem Mol Biol, in press / Translational studies on aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer. by Brueggemeier
10.1210/jc.2004-2029 / J Clin Endocrinol Metab / Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells. by Diaz-Cruz (2005)
10.3109/07357909809032891 / Cancer Invest / Mechanisms of action of antiestrogens: relevance to clinical benefits and risks. by Carmichael (1998)
10.1146/annurev.pa.35.040195.001211 / Annu Rev Pharmacol Toxicol / Tamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancer. by Jordan (1995)
{'issue': 'Suppl', 'key': '2019041122335472500_R37', 'first-page': '3261s', 'article-title': 'Aromatase: new perspectives for breast cancer.', 'volume': '42', 'author': 'Harvey', 'year': '1982', 'journal-title': 'Cancer Res'} / Cancer Res / Aromatase: new perspectives for breast cancer. by Harvey (1982)
10.1016/0039-128X(83)90056-9 / Steroids / Aromatase conference: future perspectives. by Santen (1987)
{'key': '2019041122335472500_R39', 'first-page': '321', 'article-title': 'Proceedings of the Third International Aromatase Conference.', 'volume': '44', 'author': 'Brodie', 'year': '1993', 'journal-title': 'J Steroid Biochem Mol Biol'} / J Steroid Biochem Mol Biol / Proceedings of the Third International Aromatase Conference. by Brodie (1993)
{'key': '2019041122335472500_R40', 'first-page': '107', 'article-title': 'Proceedings of the Fourth International Aromatase Conference.', 'volume': '61', 'author': 'Simpson', 'year': '1997', 'journal-title': 'J Steroid Biochem Mol Biol'} / J Steroid Biochem Mol Biol / Proceedings of the Fourth International Aromatase Conference. by Simpson (1997)
10.1016/S0960-0760(01)00191-1 / J Steroid Biochem Mol Biol / Aromatase 2000: Sixth International Aromatase Conference. by Simpson (2001)
{'key': '2019041122335472500_R42', 'first-page': '307', 'author': 'Johnston', 'year': '1984'} by Johnston (1984)
10.3109/14756368809040728 / J Enzym Inhib / Structure-activity relationships for non-steroidal inhibitors of aromatase. by Banting (1988)
10.1016/S0079-6468(08)70242-X / Prog Med Chem / Recent developments in aromatase inhibition as a potential treatment for oestrogen-dependent breast cancer. by Banting (1989)
{'key': '2019041122335472500_R45', 'first-page': '534', 'author': 'Covey', 'year': '1988'} by Covey (1988)
10.3109/14756369009040731 / J Enzym Inhib / Biochemical and molecular aspects of aromatase. by Brueggemeier (1990)
10.1007/BF00682739 / Breast Cancer Res Treat / Aromatase inhibitors—mechanisms of steroidal inhibitors. by Brueggemeier (1994)
10.1021/jm00173a001 / J Med Chem / Mechanism and inhibition of cytochrome P-450 aromatase. by Cole (1990)
{'key': '2019041122335472500_R49', 'first-page': '10', 'article-title': 'Aromatase inhibitors and breast cancer.', 'volume': '23', 'author': 'Brodie', 'year': '1996', 'journal-title': 'Semin Oncol'} / Semin Oncol / Aromatase inhibitors and breast cancer. by Brodie (1996)
10.1016/S0960-0760(99)00051-5 / J Steroid Biochem Mol Biol / Aromatase and its inhibitors. by Brodie (1999)
10.1677/erc.0.0060075 / Endocr Relat Cancer / Use of aromatase inhibitors in breast carcinoma. by Santen (1999)
10.1210/endo-92-3-866 / Endocrinology / Studies on the mechanism of estrogen biosynthesis. 8. The development of inhibitors of the enzyme system in human placenta. by Schwarzel (1973)
10.1016/0022-4731(75)90149-1 / J Steroid Biochem / Studies of human placental aromatase. by Siiteri (1975)
10.1021/jm00208a002 / J Med Chem / Synthesis and biochemical evaluation of inhibitors of estrogen biosynthesis. by Brueggemeier (1978)
10.1016/0022-4731(86)90069-5 / J Steroid Biochem / 1-Methyl-1,4-androstadiene-3,17-dione (SH 489): characterization of an irreversible inhibitor of estrogen biosynthesis. by Henderson (1986)
{'key': '2019041122335472500_R56', 'first-page': '4548', 'article-title': 'Effects of the aromatase inhibitor 7 α-(4′-amino)phenylthio-4-androstene-3,17-dione in MCF-7 human mammary carcinoma cell culture.', 'volume': '47', 'author': 'Brueggemeier', 'year': '1987', 'journal-title': 'Cancer Res'} / Cancer Res / Effects of the aromatase inhibitor 7 α-(4′-amino)phenylthio-4-androstene-3,17-dione in MCF-7 human mammary carcinoma cell culture. by Brueggemeier (1987)
10.1016/0960-0760(92)90228-B / J Steroid Biochem Mol Biol / Aromatase inhibition by 7-substituted steroids in human choriocarcinoma cell culture. by Brueggemeier (1992)
{'key': '2019041122335472500_R58', 'first-page': '6808', 'article-title': 'Effects of the aromatase inhibitor 7 α-(4′-amino)phenylthio-4-androstene-3,17-dione on 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats.', 'volume': '48', 'author': 'Brueggemeier', 'year': '1988', 'journal-title': 'Cancer Res'} / Cancer Res / Effects of the aromatase inhibitor 7 α-(4′-amino)phenylthio-4-androstene-3,17-dione on 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats. by Brueggemeier (1988)
10.1021/jm00163a017 / J Med Chem / Synthesis and biochemical studies of 7-substituted 4,6-androstadiene-3,17-diones as aromatase inhibitors. by Li (1990)
10.1016/S0021-9258(18)61365-1 / J Biol Chem / Inhibition of aromatase cytochrome P-450 by 10-oxirane and 10-thiirane substituted androgens. Implications for the structure of the active site. by Kellis (1987)
10.1016/0039-128X(83)90066-1 / Steroids / Stereoselective inhibition of human placental aromatase. by Childers (1987)
10.1039/c39870000213 / J Chem Soc Chem Comm / Stereoselective inhibition of aromatase by novel epoxysteroids. by Shih (1987)
10.1021/jm00383a014 / J Med Chem / Thiol-containing androgens as suicide substrates of aromatase. by Bednarski (1985)
10.1039/c39850001733 / J Chem Soc Chem Comm / Steroidal C-19 sulfur and nitrogen derivatives designed as aromatase inhibitors. by Wright (1985)
10.1021/jm00095a030 / J Med Chem / Time-dependent inhibition of human placental aromatase with a 2,19-methyleneoxy-bridged androstenedione. by Peet (1992)
10.1016/0960-0760(93)90244-Q / J Steroid Biochem Mol Biol / A-ring bridged steroids as potent inhibitors of aromatase. by Peet (1993)
10.1016/0960-0760(93)90269-3 / J Steroid Biochem Mol Biol / Biological characterization of A-ring steroids. by Johnston (1993)
10.1021/ja00401a054 / J Am Chem Soc / Substrate-induced inactivation of aromatase by allenic and acetylenic steroids. by Metcalf (1981)
10.1016/S0021-9258(19)69924-2 / J Biol Chem / 10β-Propynyl-substituted steroids. Mechanism-based enzyme-activated irreversible inhibitors of estrogen biosynthesis. by Covey (1981)
10.1016/0039-128X(82)90151-9 / Steroids / Synthesis and evaluation of 10β-substituted 4-estrene-3,17-diones as inhibitors of human placental microsomal aromatase. by Marcotte (1982)
10.1210/endo-115-2-776 / Endocrinology / Biochemical and endocrine properties of a mechanism-based inhibitor of aromatase. by Johnston (1984)
10.1016/0022-4731(84)90148-1 / J Steroid Biochem / Time-dependent inhibition of aromatase in trophoblastic tumor cells in tissue culture. by Johnston (1984)
10.1210/endo-122-5-2007 / Endocrinology / Inhibition of peripheral aromatization in baboons by an enzyme-activated aromatase inhibitor (MDL 18,962). by Longcope (1988)
10.1016/0039-128X(83)90065-X / Steroids / Biological characterization of 10-(2-propynyl) estr-4-ene-3,17-dione (MDL 18,962), an enzyme-activated inhibitor of aromatase. by Johnston (1987)
10.1016/0039-128X(81)90087-8 / Steroids / Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo. by Brodie (1981)
10.1210/endo-100-6-1684 / Endocrinology / The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione, on estrogen-dependent processes in reproduction and breast cancer. by Brodie (1977)
{'key': '2019041122335472500_R77', 'first-page': '2425', 'article-title': 'Effects of aromatase inhibitors, aminoglutethimide, and 4-hydroxyandrostenedione on cyclic rats and rats with 7,12-dimethylbenz(a)anthracene-induced mammary tumors.', 'volume': '45', 'author': 'Wing', 'year': '1985', 'journal-title': 'Cancer Res'} / Cancer Res / Effects of aromatase inhibitors, aminoglutethimide, and 4-hydroxyandrostenedione on cyclic rats and rats with 7,12-dimethylbenz(a)anthracene-induced mammary tumors. by Wing (1985)
{'issue': 'Suppl', 'key': '2019041122335472500_R78', 'first-page': '3360s', 'article-title': 'Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.', 'volume': '42', 'author': 'Brodie', 'year': '1982', 'journal-title': 'Cancer Res'} / Cancer Res / Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model. by Brodie (1982)
10.1016/S0140-6736(84)92795-8 / Lancet / 4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer. by Coombes (1984)
{'key': '2019041122335472500_R80', 'first-page': '4823', 'article-title': 'Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report.', 'volume': '46', 'author': 'Goss', 'year': '1986', 'journal-title': 'Cancer Res'} / Cancer Res / Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report. by Goss (1986)
{'issue': 'Suppl 7', 'key': '2019041122335472500_R81', 'first-page': 'S3', 'article-title': 'Aromatase inhibition: basic concepts, and the pharmacodynamics of formestane', 'volume': '5', 'author': 'Dowsett', 'year': '1994', 'journal-title': 'Ann Oncol'} / Ann Oncol / Aromatase inhibition: basic concepts, and the pharmacodynamics of formestane by Dowsett (1994)
10.1016/0022-4731(86)90128-7 / J Steroid Biochem / Metabolism of the aromatase inhibitor 4-hydroxyandrostenedione in vivo. Identification of the glucuronide as a major urinary metabolite in patients and biliary metabolite in the rat. by Goss (1986)
10.2165/00002512-199609040-00006 / Drugs Aging / Formestane. A review of its pharmacological properties and clinical efficacy in the treatment of postmenopausal breast cancer. by Wiseman (1996)
10.1210/endo-108-4-1597 / Endocrinology / Enzyme-generated intermediates derived from 4-androstene-3,6,17-trione and 1,4,6-androstatriene-3,17-dione cause a time-dependent decrease in human placental aromatase activity. by Covey (1981)
{'key': '2019041122335472500_R85', 'first-page': '173', 'article-title': 'Aromatase enzyme catalysis is involved in the potent inhibition of estrogen biosynthesis caused by 4-ace.', 'volume': '21', 'author': 'Covey', 'year': '1982', 'journal-title': 'Mol Pharmacol'} / Mol Pharmacol / Aromatase enzyme catalysis is involved in the potent inhibition of estrogen biosynthesis caused by 4-ace. by Covey (1982)
10.1016/S0021-9258(18)47468-6 / J Biol Chem / Potent enzyme-activated inhibition of aromatase by a 7α-substituted C19 steroid. by Snider (1987)
10.1016/0022-4731(90)90170-W / J Steroid Biochem / 7-Substituted 1,4,6-androstatriene-3,17-diones as enzyme-activated irreversible inhibitors of aromatase. by Li (1990)
10.1016/0039-128X(93)90081-W / Steroids / Synthesis and biochemical studies of 7α-substituted androsta-1,4-diene-3,17-diones as enzyme-activated irreversible inhibitors of aromatase. by Ebrahimian (1993)
10.1016/S0960-0760(96)00087-8 / J Steroid Biochem Mol Biol / 7α-Arylaliphatic androsta-1,4-diene-3,17-diones as enzyme-activated irreversible inhibitors of aromatase. by O’Reilly (1996)
10.1016/0022-4731(88)90129-X / J Steroid Biochem / 6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): a new irreversible aromatase inhibitor. by Giudici (1988)
10.1007/BF00258457 / Cancer Chemother Pharmacol / A new irreversible aromatase inhibitor, 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304): antitumor activity and endocrine effects in rats with DMBA-induced mammary tumors. by Zaccheo (1989)
10.1016/0960-0760(93)90280-A / J Steroid Biochem Mol Biol / Inhibitory effect of combined treatment with the aromatase inhibitor exemestane and tamoxifen on DMBA-induced mammary tumors in rats. by Zaccheo (1993)
10.1111/j.1749-6632.1990.tb34309.x / Ann NY Acad Sci / Novel irreversible aromatase inhibitors. by Di Salle (1990)
10.1016/0960-0760(90)90488-7 / J Steroid Biochem Mol Biol / Biochemical and pharmacological development of steroidal inhibitors of aromatase. by Brueggemeier (1990)
10.1007/BF00682741 / Breast Cancer Res Treat / First generation aromatase inhibitors—aminoglutethimide and testololactone. by Cocconi (1994)
10.1016/0305-7372(93)90006-D / Cancer Treat Rev / Experience with aromatase inhibitors in the treatment of advanced breast cancer by Hoffken (1993)
10.1016/S0960-0760(97)80018-0 / J Steroid Biochem Mol Biol / Clinical use of aromatase inhibitors in the treatment of advanced breast cancer. by Trunet (1997)
10.1021/jm00062a012 / J Med Chem / Aromatase inhibitors: synthesis, biological activity, and binding mode of azole-type compounds. by Furet (1993)
10.1016/0006-2952(90)90346-M / Biochem Pharmacol / R 76713 and enantiomers: selective, nonsteroidal inhibitors of the cytochrome P450-dependent oestrogen synthesis. by Vanden Bossche (1990)
10.1007/BF00682743 / Breast Cancer Res Treat / Vorozole, a specific non-steroidal aromatase inhibitor. by Wouters (1994)
10.1007/BF00682745 / Breast Cancer Res Treat / Arimidex: a potent and selective fourth-generation aromatase inhibitor. by Plourde (1994)
10.1016/0960-0760(90)90460-3 / J Steroid Biochem Mol Biol / Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor. by Bhatnagar (1990)
10.1007/BF00682744 / Breast Cancer Res Treat / Effects of Fadrozole (CGS 16949A) and Letrozole (CGS 20267) on the inhibition of aromatase activity in breast cancer patients. by Demers (1994)
10.1289/ehp.95103s7103 / Environ Health Perspect / Phytoestrogens: epidemiology and a possible role in cancer protection by Adlercreutz (1995)
10.1016/0960-0760(94)90030-2 / J Steroid Biochem Mol Biol / Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. by Wang (1994)
10.1126/science.6474163 / Science / Inhibition of human estrogen synthetase (aromatase) by flavones. by Kellis Jr (1984)
10.1016/0960-0760(90)90335-I / J Steroid Biochem Mol Biol / Aromatase inhibition by flavonoids. by Ibrahim (1990)
10.1016/S0304-3835(98)00211-0 / Cancer Lett / Aromatase and 17β-hydroxysteroid dehydrogenase inhibition by flavonoids. by Le Bail (1998)
10.1016/S0024-3205(00)00974-7 / Life Sci / Chalcones are potent inhibitors of aromatase and 17β-hydroxysteroid dehydrogenase activities. by Le Bail (2001)
10.1289/ehp.9810685 / Environ Health Perspect / Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: a site-directed mutagenesis study. by Kao (1998)
10.1023/A:1014490817731 / Pharm Res / Synthesis and aromatase inhibitory activity of flavanones. by Pouget (2002)
10.1016/S0960-894X(02)00565-6 / Bioorg Med Chem Lett / Design, synthesis and evaluation of 4-imidazolylflavans as new leads for aromatase inhibition. by Pouget (2002)
10.1021/jm000955s / J Med Chem / A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17α-hydroxylase/C17,20-lyase. by Recanatini (2001)
10.1016/S0960-0760(01)00127-3 / J Steroid Biochem Mol Biol / Molecular pharmacology of aromatase and its regulation by endogenous and exogenous agents. by Brueggemeier (2001)
10.1016/S0009-2797(01)00285-X / Chem Biol Interact / Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. by Hodek (2002)
10.1021/jm0306024 / J Med Chem / Synthesis and aromatase inhibitory activity of novel pyridine-containing isoflavones. by Kim (2004)
10.1002/1097-0142(197402)33:2<503::AID-CNCR2820330227>3.0.CO;2-L / Cancer / Proceedings: medical adrenalectomy using aminoglutethimide and dexamethasone in advanced breast cancer. by Lipton (1974)
10.1002/1097-0142(197706)39:6<2948::AID-CNCR2820390681>3.0.CO;2-9 / Cancer / Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. by Santen (1977)
10.1210/edrv-11-2-221 / Endocr Rev / Endocrine treatment of breast cancer in women. by Santen (1990)
10.1016/0960-0760(94)90269-0 / J Steroid Biochem Mol Biol / Aromatase inhibitors in the treatment of breast cancer. by Brodie (1994)
10.1200/JCO.2001.19.3.881 / J Clin Oncol / Aromatase inhibitors in the treatment and prevention of breast cancer. by Goss (2001)
{'key': '2019041122335472500_R122', 'first-page': '4392', 'article-title': 'Current status of adjuvant endocrine therapy for breast cancer.', 'volume': '7', 'author': 'Ingle', 'year': '2001', 'journal-title': 'Clin Cancer Res'} / Clin Cancer Res / Current status of adjuvant endocrine therapy for breast cancer. by Ingle (2001)
{'key': '2019041122335472500_R123', 'first-page': '2620', 'article-title': 'Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer.', 'volume': '7', 'author': 'Buzdar', 'year': '2001', 'journal-title': 'Clin Cancer Res'} / Clin Cancer Res / Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer. by Buzdar (2001)
10.1007/s002800100345 / Cancer Chemother Pharmacol / Role of anti-aromatase agents in postmenopausal advanced breast cancer. by Murray (2001)
{'key': '2019041122335472500_R125', 'first-page': '965', 'article-title': 'Nonsteroidal and steroidal aromatase inhibitors in breast cancer.', 'volume': '15', 'author': 'Hamilton', 'year': '2001', 'journal-title': 'Oncology (Huntingt)'} / Oncology (Huntingt) / Nonsteroidal and steroidal aromatase inhibitors in breast cancer. by Hamilton (2001)
10.1016/S0093-7754(01)90122-8 / Semin Oncol / Endocrine therapy in the treatment of metastatic breast cancer. by Buzdar (2001)
10.1038/bjc.1996.531 / Br J Cancer / Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatization and plasma oestrogen levels in postmenopausal women with breast cancer. by Geisler (1996)
10.1016/0959-8049(95)00014-3 / Eur J Cancer / A randomized trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer by Jonat (1996)
10.1002/(SICI)1097-0142(19970215)79:4<730::AID-CNCR10>3.0.CO;2-0 / Cancer / A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. Arimidex Study Group. by Buzdar (1997)
10.1200/JCO.1996.14.7.2000 / J Clin Oncol / Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. by Buzdar (1996)
10.1200/JCO.2000.18.22.3748 / J Clin Oncol / Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study. by Bonneterre (2000)
10.1200/JCO.2000.18.22.3758 / J Clin Oncol / Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group. by Nabholtz (2000)
10.1002/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO;2-Y / Cancer / Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma. by Bonneterre (2001)
10.1038/bjc.1996.531 / Br J Cancer by Geisler
10.1093/annonc/mdf083 / Ann Oncol / Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism. by Bajetta (2002)
{'key': '2019041122335472500_R136', 'first-page': '1511', 'article-title': 'In vivo measurement of aromatase inhibition by letrozole (CGS 20267) in postmenopausal patients with breast cancer.', 'volume': '1', 'author': 'Dowsett', 'year': '1995', 'journal-title': 'Clin Cancer Res'} / Clin Cancer Res / In vivo measurement of aromatase inhibition by letrozole (CGS 20267) in postmenopausal patients with breast cancer. by Dowsett (1995)
10.1200/JCO.1998.16.2.453 / J Clin Oncol / Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate. by Dombernowsky (1998)
10.1200/JCO.2001.19.14.3357 / J Clin Oncol / Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate. by Buzdar (2001)
10.1016/S0959-8049(98)00392-X / Eur J Cancer / Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients. by Bajetta (1999)
10.1200/JCO.2001.19.10.2596 / J Clin Oncol / Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group. by Mouridsen (2001)
10.1200/JCO.2002.20.3.751 / J Clin Oncol / Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study. by Geisler (2002)
{'key': '2019041122335472500_R142', 'first-page': '5933', 'article-title': 'Phase I and endocrine study of exemestane (FCE 24304), a new aromatase inhibitor, in postmenopausal women.', 'volume': '52', 'author': 'Evans', 'year': '1992', 'journal-title': 'Cancer Res'} / Cancer Res / Phase I and endocrine study of exemestane (FCE 24304), a new aromatase inhibitor, in postmenopausal women. by Evans (1992)
10.1016/S0959-8049(96)00494-7 / Eur J Cancer / The minimal effective exemestane dose for endocrine activity in advanced breast cancer. by Bajetta (1997)
{'key': '2019041122335472500_R144', 'first-page': '2089', 'article-title': 'In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients.', 'volume': '4', 'author': 'Geisler', 'year': '1998', 'journal-title': 'Clin Cancer Res'} / Clin Cancer Res / In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients. by Geisler (1998)
10.1200/JCO.2000.18.11.2234 / J Clin Oncol / Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors: a phase II trial. by Lonning (2000)
10.1517/13543784.9.8.1897 / Expert Opin Investig Drugs / Pharmacology and clinical experience with exemestane. by Lonning (2000)
{'key': '2019041122335472500_R147', 'first-page': '1101', 'article-title': 'Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: a phase I study.', 'volume': '3', 'author': 'Johannessen', 'year': '1997', 'journal-title': 'Clin Cancer Res'} / Clin Cancer Res / Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: a phase I study. by Johannessen (1997)
10.1016/S0960-0760(01)00126-1 / J Steroid Biochem Mol Biol / Comparative clinical pharmacology and pharmacokinetic interactions of aromatase inhibitors. by Boeddinghaus (2001)
10.1177/107327480200902S02 / Cancer Control / Endocrine and clinical endpoints of exemestane as neoadjuvant therapy. by Miller (2002)
10.1016/S0960-0760(97)00072-1 / J Steroid Biochem Mol Biol / Mechanisms of the actions of aromatase inhibitors 4-hydroxyandrostenedione, fadrozole, and aminoglutethimide on aromatase in JEG-3 cell culture. by Yue (1997)
10.3816/CBC.2000.s.013 / Clin Breast Cancer / Comparison of in vitro exemestane activity versus other antiaromatase agents by Soudon (2000)
10.3816/CBC.2000.s.002 / Clin Breast Cancer / Antiaromatase agents: preclinical data and neoadjuvant therapy by Miller (2000)
10.1097/00000421-200308001-00004 / Am J Clin Oncol / Applicability of the intratumor aromatase preclinical model to predict clinical trial results with endocrine therapy by Brodie (2003)
10.1093/annonc/mdg362 / Ann Oncol / Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer. by Paridaens (2003)
{'key': '2019041122335472500_R155', 'first-page': '28', 'article-title': 'Aromatase inhibition and antiestrogen therapy in early breast cancer treatment and chemoprevention.', 'volume': '15', 'author': 'Ingle', 'year': '2001', 'journal-title': 'Oncology (Huntingt)'} / Oncology (Huntingt) / Aromatase inhibition and antiestrogen therapy in early breast cancer treatment and chemoprevention. by Ingle (2001)
10.1634/theoncologist.8-4-335 / Oncologist / Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer. by Buzdar (2003)
10.1016/S0140-6736(02)09088-8 / Lancet / Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. by Baum (2002)
10.1002/cncr.11745 / Cancer / Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. by Baum (2003)
10.1056/NEJMoa032312 / N Engl J Med / A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. by Goss (2003)
10.1056/NEJMoa040331 / N Engl J Med / A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. by Coombes (2004)
10.1200/JCO.2005.09.121 / J Clin Oncol / American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. by Winer (2005)
{'key': '2019041122335472500_R162', 'first-page': '889', 'article-title': 'Chemoprevention of MNU-induced mammary tumorigenesis by hormone response modifiers: toremifene, RU 16117, tamoxifen, aminoglutethimide and progesterone.', 'volume': '14', 'author': 'Moon', 'year': '1994', 'journal-title': 'Anticancer Res'} / Anticancer Res / Chemoprevention of MNU-induced mammary tumorigenesis by hormone response modifiers: toremifene, RU 16117, tamoxifen, aminoglutethimide and progesterone. by Moon (1994)
{'key': '2019041122335472500_R163', 'first-page': '1240', 'article-title': 'Antitumoral and endocrine effects of (+)-vorozole in rats bearing dimethylbenzanthracene-induced mammary tumors.', 'volume': '52', 'author': 'De Coster', 'year': '1992', 'journal-title': 'Cancer Res'} / Cancer Res / Antitumoral and endocrine effects of (+)-vorozole in rats bearing dimethylbenzanthracene-induced mammary tumors. by De Coster (1992)
10.1093/carcin/15.12.2775 / Carcinogenesis / Chemopreventive effects of the aromatase inhibitors vorozole (R-83842) and 4-hydroxyandrostenedione in the methylnitrosourea (MNU)-induced mammary tumor model in Sprague-Dawley rats. by Lubet (1994)
10.1016/0960-0760(93)90270-7 / J Steroid Biochem Mol Biol / Anti-tumor and endocrine effects of non-steroidal aromatase inhibitors on estrogen-dependent rat mammary tumors. by Schieweck (1993)
10.1016/S0960-0760(03)00378-9 / J Steroid Biochem Mol Biol / Breast cancer prevention—clinical trials strategies involving aromatase inhibitors. by Goss (2003)

Dates

Type	When
Created	20 years, 3 months ago (May 16, 2005, 2:38 p.m.)
Deposited	4 years, 1 month ago (July 10, 2021, 8:47 p.m.)
Indexed	2 weeks, 3 days ago (Aug. 19, 2025, 6:13 a.m.)
Issued	20 years, 4 months ago (April 6, 2005)
Published	20 years, 4 months ago (April 6, 2005)
Published Online	20 years, 4 months ago (April 6, 2005)
Published Print	20 years, 4 months ago (May 1, 2005)

Funders 0

None

BibTeX

@article{Brueggemeier_2005, title={Aromatase Inhibitors in the Treatment of Breast Cancer}, volume={26}, ISSN={1945-7189}, url={http://dx.doi.org/10.1210/er.2004-0015}, DOI={10.1210/er.2004-0015}, number={3}, journal={Endocrine Reviews}, publisher={The Endocrine Society}, author={Brueggemeier, Robert W. and Hackett, John C. and Diaz-Cruz, Edgar S.}, year={2005}, month=apr, pages={331–345} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        8,
        19
      ]
    ],
    "date-time": "2025-08-19T10:13:22Z",
    "timestamp": 1755598402100
  },
  "reference-count": 166,
  "publisher": "The Endocrine Society",
  "issue": "3",
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2005,
        5,
        1
      ]
    ]
  },
  "DOI": "10.1210/er.2004-0015",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2005,
        5,
        16
      ]
    ],
    "date-time": "2005-05-16T18:38:39Z",
    "timestamp": 1116268719000
  },
  "page": "331-345",
  "source": "Crossref",
  "is-referenced-by-count": 381,
  "title": "Aromatase Inhibitors in the Treatment of Breast Cancer",
  "prefix": "10.1210",
  "volume": "26",
  "author": [
    {
      "given": "Robert W.",
      "family": "Brueggemeier",
      "sequence": "first",
      "affiliation": [
        {
          "name": "Medicinal Chemistry and Pharmacognosy, College of Pharmacy, and Hormones and Cancer Program, Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210"
        }
      ]
    },
    {
      "given": "John C.",
      "family": "Hackett",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "Medicinal Chemistry and Pharmacognosy, College of Pharmacy, and Hormones and Cancer Program, Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210"
        }
      ]
    },
    {
      "given": "Edgar S.",
      "family": "Diaz-Cruz",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "Medicinal Chemistry and Pharmacognosy, College of Pharmacy, and Hormones and Cancer Program, Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210"
        }
      ]
    }
  ],
  "member": "80",
  "published-online": {
    "date-parts": [
      [
        2005,
        4,
        6
      ]
    ]
  },
  "reference": [
    {
      "key": "2019041122335472500_R1",
      "year": "2004"
    },
    {
      "key": "2019041122335472500_R2",
      "first-page": "2053",
      "author": "Weigel",
      "year": "2001"
    },
    {
      "key": "2019041122335472500_R3",
      "first-page": "358",
      "author": "Dickson",
      "year": "1995"
    },
    {
      "key": "2019041122335472500_R4",
      "first-page": "342",
      "article-title": "Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis.",
      "volume": "15",
      "author": "Simpson",
      "year": "1994",
      "journal-title": "Endocr Rev"
    },
    {
      "key": "2019041122335472500_R5",
      "doi-asserted-by": "crossref",
      "first-page": "269",
      "DOI": "10.1016/0039-128X(83)90077-6",
      "article-title": "Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies.",
      "volume": "50",
      "author": "James",
      "year": "1987",
      "journal-title": "Steroids"
    },
    {
      "key": "2019041122335472500_R6",
      "doi-asserted-by": "crossref",
      "first-page": "537",
      "DOI": "10.1016/0039-128X(87)90037-7",
      "article-title": "The importance of local synthesis of estrogen within the breast.",
      "volume": "50",
      "author": "Miller",
      "year": "1987",
      "journal-title": "Steroids"
    },
    {
      "key": "2019041122335472500_R7",
      "doi-asserted-by": "crossref",
      "first-page": "233",
      "DOI": "10.1002/ijc.2910440208",
      "article-title": "In situ oestrone synthesis in normal breast and breast tumour tissues: effect of treatment with 4-hydroxyandrostenedione.",
      "volume": "44",
      "author": "Reed",
      "year": "1989",
      "journal-title": "Int J Cancer"
    },
    {
      "key": "2019041122335472500_R8",
      "first-page": "1622",
      "article-title": "A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription.",
      "volume": "77",
      "author": "Bulun",
      "year": "1993",
      "journal-title": "J Clin Endocrinol Metab"
    },
    {
      "key": "2019041122335472500_R9",
      "doi-asserted-by": "crossref",
      "first-page": "321",
      "DOI": "10.1016/0960-0760(93)90235-O",
      "article-title": "Tissue-specific promoters regulate aromatase cytochrome P450 expression.",
      "volume": "44",
      "author": "Simpson",
      "year": "1993",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R10",
      "doi-asserted-by": "crossref",
      "first-page": "4413",
      "DOI": "10.1016/S0021-9258(18)61364-X",
      "article-title": "Purification and characterization of human placental aromatase cytochrome P-450.",
      "volume": "262",
      "author": "Kellis",
      "year": "1987",
      "journal-title": "J Biol Chem"
    },
    {
      "key": "2019041122335472500_R11",
      "doi-asserted-by": "crossref",
      "first-page": "569",
      "DOI": "10.1042/bj2010569",
      "article-title": "Mechanistic studies on C-19 demethylation in oestrogen biosynthesis.",
      "volume": "201",
      "author": "Akhtar",
      "year": "1982",
      "journal-title": "Biochem J"
    },
    {
      "key": "2019041122335472500_R12",
      "doi-asserted-by": "crossref",
      "first-page": "1065",
      "DOI": "10.1002/pro.5560040605",
      "article-title": "A three-dimensional model of aromatase cytochrome P450.",
      "volume": "4",
      "author": "Graham-Lorence",
      "year": "1995",
      "journal-title": "Protein Sci"
    },
    {
      "key": "2019041122335472500_R13",
      "doi-asserted-by": "crossref",
      "DOI": "10.1021/ja044716w",
      "article-title": "The final catalytic step of cytochrome P450 aromatase: a density functional theory study.",
      "author": "Hackett",
      "year": "2005",
      "journal-title": "J Am Chem Soc 10.1021/ja044716w"
    },
    {
      "key": "2019041122335472500_R14",
      "doi-asserted-by": "crossref",
      "first-page": "3947",
      "DOI": "10.1021/cr020443g",
      "article-title": "Mechanism of oxidation reactions catalyzed by cytochrome p450 enzymes.",
      "volume": "104",
      "author": "Meunier",
      "year": "2004",
      "journal-title": "Chem Rev"
    },
    {
      "key": "2019041122335472500_R15",
      "doi-asserted-by": "crossref",
      "first-page": "5",
      "DOI": "10.1055/s-2004-823022",
      "article-title": "Organization of the human aromatase p450 (CYP19) gene.",
      "volume": "22",
      "author": "Bulun",
      "year": "2004",
      "journal-title": "Semin Reprod Med"
    },
    {
      "key": "2019041122335472500_R16",
      "doi-asserted-by": "crossref",
      "first-page": "443",
      "DOI": "10.1006/prep.2001.1464",
      "article-title": "Human aromatase in high yield and purity by perfusion chromatography and its characterization by difference spectroscopy and mass spectrometry.",
      "volume": "22",
      "author": "Gartner",
      "year": "2001",
      "journal-title": "Protein Expr Purif"
    },
    {
      "key": "2019041122335472500_R17",
      "doi-asserted-by": "crossref",
      "first-page": "203",
      "DOI": "10.1016/S0960-0760(97)80013-1",
      "article-title": "Transcriptional regulation of CYP19 gene (aromatase) expression in adipose stromal cells in primary culture.",
      "volume": "61",
      "author": "Zhao",
      "year": "1997",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R18",
      "doi-asserted-by": "crossref",
      "first-page": "93",
      "DOI": "10.1146/annurev.physiol.64.081601.142703",
      "article-title": "Aromatase\u2014a brief overview.",
      "volume": "64",
      "author": "Simpson",
      "year": "2002",
      "journal-title": "Annu Rev Physiol"
    },
    {
      "key": "2019041122335472500_R19",
      "doi-asserted-by": "crossref",
      "first-page": "605",
      "DOI": "10.1016/0960-0760(93)90266-Y",
      "article-title": "Control of aromatase in breast cancer cells and its importance for tumor growth.",
      "volume": "44",
      "author": "Dowsett",
      "year": "1993",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R20",
      "doi-asserted-by": "crossref",
      "first-page": "193",
      "DOI": "10.1016/S0960-0760(97)80012-X",
      "article-title": "Regulation of aromatase activity within the breast.",
      "volume": "61",
      "author": "Miller",
      "year": "1997",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R21",
      "doi-asserted-by": "crossref",
      "first-page": "589",
      "DOI": "10.1016/0960-0760(93)90264-W",
      "article-title": "Control of aromatase activity in breast cancer cells: the role of cytokines and growth factors.",
      "volume": "44",
      "author": "Reed",
      "year": "1993",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R22",
      "doi-asserted-by": "crossref",
      "first-page": "249",
      "DOI": "10.1016/S0960-0760(99)00113-2",
      "article-title": "Effects of matrix components on aromatase activity in breast stromal cells in culture.",
      "volume": "70",
      "author": "Quinn",
      "year": "1999",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R23",
      "doi-asserted-by": "crossref",
      "first-page": "239",
      "DOI": "10.1016/S0960-0760(03)00363-7",
      "article-title": "Validation of new aromatase monoclonal antibodies for immunohistochemistry: progress report.",
      "volume": "86",
      "author": "Sasano",
      "year": "2003",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R24",
      "doi-asserted-by": "crossref",
      "first-page": "5739",
      "DOI": "10.1210/endo.137.12.8940410",
      "article-title": "Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene.",
      "volume": "137",
      "author": "Zhao",
      "year": "1996",
      "journal-title": "Endocrinology"
    },
    {
      "key": "2019041122335472500_R25",
      "doi-asserted-by": "crossref",
      "first-page": "684",
      "DOI": "10.1002/(SICI)1097-0215(19960904)67:5<684::AID-IJC16>3.0.CO;2-5",
      "article-title": "Regulation of arachidonic acid metabolism, aromatase activity and growth in human breast cancer cells by interleukin-1\u03b2 and phorbol ester: dissociation of a mediatory role for prostaglandin E2 in the autocrine control of cell function.",
      "volume": "67",
      "author": "Hughes",
      "year": "1996",
      "journal-title": "Int J Cancer"
    },
    {
      "key": "2019041122335472500_R26",
      "doi-asserted-by": "crossref",
      "first-page": "203",
      "DOI": "10.1097/00001648-199603000-00017",
      "article-title": "Nonsteroidal antiinflammatory drugs and breast cancer.",
      "volume": "7",
      "author": "Harris",
      "year": "1996",
      "journal-title": "Epidemiology"
    },
    {
      "key": "2019041122335472500_R27",
      "doi-asserted-by": "crossref",
      "first-page": "291",
      "DOI": "10.1054/mehy.1998.0009",
      "article-title": "Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP19): an extension of the dietary fat hypothesis of breast cancer.",
      "volume": "52",
      "author": "Harris",
      "year": "1999",
      "journal-title": "Med Hypotheses"
    },
    {
      "key": "2019041122335472500_R28",
      "doi-asserted-by": "crossref",
      "first-page": "22",
      "DOI": "10.1053/j.seminoncol.2004.03.042",
      "article-title": "The role of COX-2 inhibition in breast cancer treatment and prevention.",
      "volume": "31",
      "author": "Arun",
      "year": "2004",
      "journal-title": "Semin Oncol"
    },
    {
      "key": "2019041122335472500_R29",
      "doi-asserted-by": "crossref",
      "first-page": "2433",
      "DOI": "10.1001/jama.291.20.2433",
      "article-title": "Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk.",
      "volume": "291",
      "author": "Terry",
      "year": "2004",
      "journal-title": "JAMA"
    },
    {
      "key": "2019041122335472500_R30",
      "doi-asserted-by": "crossref",
      "first-page": "27",
      "DOI": "10.1016/S0304-3835(99)00050-6",
      "article-title": "Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens.",
      "volume": "140",
      "author": "Brueggemeier",
      "year": "1999",
      "journal-title": "Cancer Lett"
    },
    {
      "key": "2019041122335472500_R31",
      "doi-asserted-by": "crossref",
      "first-page": "41",
      "DOI": "10.1016/S0960-0760(01)00131-5",
      "article-title": "Aromatase and COX-2 expression in human breast cancers.",
      "volume": "79",
      "author": "Brodie",
      "year": "2001",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R32",
      "doi-asserted-by": "crossref",
      "first-page": "2810",
      "DOI": "10.1210/jc.2002-021475",
      "article-title": "Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes.",
      "volume": "88",
      "author": "Richards",
      "year": "2003",
      "journal-title": "J Clin Endocrinol Metab"
    },
    {
      "key": "2019041122335472500_R33",
      "article-title": "Translational studies on aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer.",
      "author": "Brueggemeier",
      "journal-title": "J Steroid Biochem Mol Biol, in press"
    },
    {
      "key": "2019041122335472500_R34",
      "doi-asserted-by": "crossref",
      "first-page": "2563",
      "DOI": "10.1210/jc.2004-2029",
      "article-title": "Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells.",
      "volume": "90",
      "author": "Diaz-Cruz",
      "year": "2005",
      "journal-title": "J Clin Endocrinol Metab"
    },
    {
      "key": "2019041122335472500_R35",
      "doi-asserted-by": "crossref",
      "first-page": "604",
      "DOI": "10.3109/07357909809032891",
      "article-title": "Mechanisms of action of antiestrogens: relevance to clinical benefits and risks.",
      "volume": "16",
      "author": "Carmichael",
      "year": "1998",
      "journal-title": "Cancer Invest"
    },
    {
      "key": "2019041122335472500_R36",
      "doi-asserted-by": "crossref",
      "first-page": "195",
      "DOI": "10.1146/annurev.pa.35.040195.001211",
      "article-title": "Tamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancer.",
      "volume": "35",
      "author": "Jordan",
      "year": "1995",
      "journal-title": "Annu Rev Pharmacol Toxicol"
    },
    {
      "issue": "Suppl",
      "key": "2019041122335472500_R37",
      "first-page": "3261s",
      "article-title": "Aromatase: new perspectives for breast cancer.",
      "volume": "42",
      "author": "Harvey",
      "year": "1982",
      "journal-title": "Cancer Res"
    },
    {
      "key": "2019041122335472500_R38",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1016/0039-128X(83)90056-9",
      "article-title": "Aromatase conference: future perspectives.",
      "volume": "50",
      "author": "Santen",
      "year": "1987",
      "journal-title": "Steroids"
    },
    {
      "key": "2019041122335472500_R39",
      "first-page": "321",
      "article-title": "Proceedings of the Third International Aromatase Conference.",
      "volume": "44",
      "author": "Brodie",
      "year": "1993",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R40",
      "first-page": "107",
      "article-title": "Proceedings of the Fourth International Aromatase Conference.",
      "volume": "61",
      "author": "Simpson",
      "year": "1997",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R41",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1016/S0960-0760(01)00191-1",
      "article-title": "Aromatase 2000: Sixth International Aromatase Conference.",
      "volume": "79",
      "author": "Simpson",
      "year": "2001",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R42",
      "first-page": "307",
      "author": "Johnston",
      "year": "1984"
    },
    {
      "key": "2019041122335472500_R43",
      "doi-asserted-by": "crossref",
      "first-page": "215",
      "DOI": "10.3109/14756368809040728",
      "article-title": "Structure-activity relationships for non-steroidal inhibitors of aromatase.",
      "volume": "2",
      "author": "Banting",
      "year": "1988",
      "journal-title": "J Enzym Inhib"
    },
    {
      "key": "2019041122335472500_R44",
      "doi-asserted-by": "crossref",
      "first-page": "253",
      "DOI": "10.1016/S0079-6468(08)70242-X",
      "article-title": "Recent developments in aromatase inhibition as a potential treatment for oestrogen-dependent breast cancer.",
      "volume": "26",
      "author": "Banting",
      "year": "1989",
      "journal-title": "Prog Med Chem"
    },
    {
      "key": "2019041122335472500_R45",
      "first-page": "534",
      "author": "Covey",
      "year": "1988"
    },
    {
      "key": "2019041122335472500_R46",
      "doi-asserted-by": "crossref",
      "first-page": "101",
      "DOI": "10.3109/14756369009040731",
      "article-title": "Biochemical and molecular aspects of aromatase.",
      "volume": "4",
      "author": "Brueggemeier",
      "year": "1990",
      "journal-title": "J Enzym Inhib"
    },
    {
      "key": "2019041122335472500_R47",
      "doi-asserted-by": "crossref",
      "first-page": "31",
      "DOI": "10.1007/BF00682739",
      "article-title": "Aromatase inhibitors\u2014mechanisms of steroidal inhibitors.",
      "volume": "30",
      "author": "Brueggemeier",
      "year": "1994",
      "journal-title": "Breast Cancer Res Treat"
    },
    {
      "key": "2019041122335472500_R48",
      "doi-asserted-by": "crossref",
      "first-page": "2933",
      "DOI": "10.1021/jm00173a001",
      "article-title": "Mechanism and inhibition of cytochrome P-450 aromatase.",
      "volume": "33",
      "author": "Cole",
      "year": "1990",
      "journal-title": "J Med Chem"
    },
    {
      "key": "2019041122335472500_R49",
      "first-page": "10",
      "article-title": "Aromatase inhibitors and breast cancer.",
      "volume": "23",
      "author": "Brodie",
      "year": "1996",
      "journal-title": "Semin Oncol"
    },
    {
      "key": "2019041122335472500_R50",
      "doi-asserted-by": "crossref",
      "first-page": "205",
      "DOI": "10.1016/S0960-0760(99)00051-5",
      "article-title": "Aromatase and its inhibitors.",
      "volume": "69",
      "author": "Brodie",
      "year": "1999",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R51",
      "doi-asserted-by": "crossref",
      "first-page": "75",
      "DOI": "10.1677/erc.0.0060075",
      "article-title": "Use of aromatase inhibitors in breast carcinoma.",
      "volume": "6",
      "author": "Santen",
      "year": "1999",
      "journal-title": "Endocr Relat Cancer"
    },
    {
      "key": "2019041122335472500_R52",
      "doi-asserted-by": "crossref",
      "first-page": "866",
      "DOI": "10.1210/endo-92-3-866",
      "article-title": "Studies on the mechanism of estrogen biosynthesis. 8. The development of inhibitors of the enzyme system in human placenta.",
      "volume": "92",
      "author": "Schwarzel",
      "year": "1973",
      "journal-title": "Endocrinology"
    },
    {
      "key": "2019041122335472500_R53",
      "doi-asserted-by": "crossref",
      "first-page": "317",
      "DOI": "10.1016/0022-4731(75)90149-1",
      "article-title": "Studies of human placental aromatase.",
      "volume": "6",
      "author": "Siiteri",
      "year": "1975",
      "journal-title": "J Steroid Biochem"
    },
    {
      "key": "2019041122335472500_R54",
      "doi-asserted-by": "crossref",
      "first-page": "1007",
      "DOI": "10.1021/jm00208a002",
      "article-title": "Synthesis and biochemical evaluation of inhibitors of estrogen biosynthesis.",
      "volume": "21",
      "author": "Brueggemeier",
      "year": "1978",
      "journal-title": "J Med Chem"
    },
    {
      "key": "2019041122335472500_R55",
      "doi-asserted-by": "crossref",
      "first-page": "303",
      "DOI": "10.1016/0022-4731(86)90069-5",
      "article-title": "1-Methyl-1,4-androstadiene-3,17-dione (SH 489): characterization of an irreversible inhibitor of estrogen biosynthesis.",
      "volume": "24",
      "author": "Henderson",
      "year": "1986",
      "journal-title": "J Steroid Biochem"
    },
    {
      "key": "2019041122335472500_R56",
      "first-page": "4548",
      "article-title": "Effects of the aromatase inhibitor 7 \u03b1-(4\u2032-amino)phenylthio-4-androstene-3,17-dione in MCF-7 human mammary carcinoma cell culture.",
      "volume": "47",
      "author": "Brueggemeier",
      "year": "1987",
      "journal-title": "Cancer Res"
    },
    {
      "key": "2019041122335472500_R57",
      "doi-asserted-by": "crossref",
      "first-page": "85",
      "DOI": "10.1016/0960-0760(92)90228-B",
      "article-title": "Aromatase inhibition by 7-substituted steroids in human choriocarcinoma cell culture.",
      "volume": "41",
      "author": "Brueggemeier",
      "year": "1992",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R58",
      "first-page": "6808",
      "article-title": "Effects of the aromatase inhibitor 7 \u03b1-(4\u2032-amino)phenylthio-4-androstene-3,17-dione on 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats.",
      "volume": "48",
      "author": "Brueggemeier",
      "year": "1988",
      "journal-title": "Cancer Res"
    },
    {
      "key": "2019041122335472500_R59",
      "doi-asserted-by": "crossref",
      "first-page": "101",
      "DOI": "10.1021/jm00163a017",
      "article-title": "Synthesis and biochemical studies of 7-substituted 4,6-androstadiene-3,17-diones as aromatase inhibitors.",
      "volume": "33",
      "author": "Li",
      "year": "1990",
      "journal-title": "J Med Chem"
    },
    {
      "key": "2019041122335472500_R60",
      "doi-asserted-by": "crossref",
      "first-page": "4421",
      "DOI": "10.1016/S0021-9258(18)61365-1",
      "article-title": "Inhibition of aromatase cytochrome P-450 by 10-oxirane and 10-thiirane substituted androgens. Implications for the structure of the active site.",
      "volume": "262",
      "author": "Kellis",
      "year": "1987",
      "journal-title": "J Biol Chem"
    },
    {
      "key": "2019041122335472500_R61",
      "doi-asserted-by": "crossref",
      "first-page": "121",
      "DOI": "10.1016/0039-128X(83)90066-1",
      "article-title": "Stereoselective inhibition of human placental aromatase.",
      "volume": "50",
      "author": "Childers",
      "year": "1987",
      "journal-title": "Steroids"
    },
    {
      "key": "2019041122335472500_R62",
      "doi-asserted-by": "crossref",
      "first-page": "213",
      "DOI": "10.1039/c39870000213",
      "article-title": "Stereoselective inhibition of aromatase by novel epoxysteroids.",
      "author": "Shih",
      "year": "1987",
      "journal-title": "J Chem Soc Chem Comm"
    },
    {
      "key": "2019041122335472500_R63",
      "doi-asserted-by": "crossref",
      "first-page": "775",
      "DOI": "10.1021/jm00383a014",
      "article-title": "Thiol-containing androgens as suicide substrates of aromatase.",
      "volume": "28",
      "author": "Bednarski",
      "year": "1985",
      "journal-title": "J Med Chem"
    },
    {
      "key": "2019041122335472500_R64",
      "doi-asserted-by": "crossref",
      "first-page": "1733",
      "DOI": "10.1039/c39850001733",
      "article-title": "Steroidal C-19 sulfur and nitrogen derivatives designed as aromatase inhibitors.",
      "author": "Wright",
      "year": "1985",
      "journal-title": "J Chem Soc Chem Comm"
    },
    {
      "key": "2019041122335472500_R65",
      "doi-asserted-by": "crossref",
      "first-page": "3303",
      "DOI": "10.1021/jm00095a030",
      "article-title": "Time-dependent inhibition of human placental aromatase with a 2,19-methyleneoxy-bridged androstenedione.",
      "volume": "35",
      "author": "Peet",
      "year": "1992",
      "journal-title": "J Med Chem"
    },
    {
      "key": "2019041122335472500_R66",
      "doi-asserted-by": "crossref",
      "first-page": "409",
      "DOI": "10.1016/0960-0760(93)90244-Q",
      "article-title": "A-ring bridged steroids as potent inhibitors of aromatase.",
      "volume": "44",
      "author": "Peet",
      "year": "1993",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R67",
      "doi-asserted-by": "crossref",
      "first-page": "623",
      "DOI": "10.1016/0960-0760(93)90269-3",
      "article-title": "Biological characterization of A-ring steroids.",
      "volume": "44",
      "author": "Johnston",
      "year": "1993",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R68",
      "doi-asserted-by": "crossref",
      "first-page": "3221",
      "DOI": "10.1021/ja00401a054",
      "article-title": "Substrate-induced inactivation of aromatase by allenic and acetylenic steroids.",
      "volume": "103",
      "author": "Metcalf",
      "year": "1981",
      "journal-title": "J Am Chem Soc"
    },
    {
      "key": "2019041122335472500_R69",
      "doi-asserted-by": "crossref",
      "first-page": "1076",
      "DOI": "10.1016/S0021-9258(19)69924-2",
      "article-title": "10\u03b2-Propynyl-substituted steroids. Mechanism-based enzyme-activated irreversible inhibitors of estrogen biosynthesis.",
      "volume": "256",
      "author": "Covey",
      "year": "1981",
      "journal-title": "J Biol Chem"
    },
    {
      "key": "2019041122335472500_R70",
      "doi-asserted-by": "crossref",
      "first-page": "325",
      "DOI": "10.1016/0039-128X(82)90151-9",
      "article-title": "Synthesis and evaluation of 10\u03b2-substituted 4-estrene-3,17-diones as inhibitors of human placental microsomal aromatase.",
      "volume": "39",
      "author": "Marcotte",
      "year": "1982",
      "journal-title": "Steroids"
    },
    {
      "key": "2019041122335472500_R71",
      "doi-asserted-by": "crossref",
      "first-page": "776",
      "DOI": "10.1210/endo-115-2-776",
      "article-title": "Biochemical and endocrine properties of a mechanism-based inhibitor of aromatase.",
      "volume": "115",
      "author": "Johnston",
      "year": "1984",
      "journal-title": "Endocrinology"
    },
    {
      "key": "2019041122335472500_R72",
      "doi-asserted-by": "crossref",
      "first-page": "1221",
      "DOI": "10.1016/0022-4731(84)90148-1",
      "article-title": "Time-dependent inhibition of aromatase in trophoblastic tumor cells in tissue culture.",
      "volume": "20",
      "author": "Johnston",
      "year": "1984",
      "journal-title": "J Steroid Biochem"
    },
    {
      "key": "2019041122335472500_R73",
      "doi-asserted-by": "crossref",
      "first-page": "2007",
      "DOI": "10.1210/endo-122-5-2007",
      "article-title": "Inhibition of peripheral aromatization in baboons by an enzyme-activated aromatase inhibitor (MDL 18,962).",
      "volume": "122",
      "author": "Longcope",
      "year": "1988",
      "journal-title": "Endocrinology"
    },
    {
      "key": "2019041122335472500_R74",
      "doi-asserted-by": "crossref",
      "first-page": "105",
      "DOI": "10.1016/0039-128X(83)90065-X",
      "article-title": "Biological characterization of 10-(2-propynyl) estr-4-ene-3,17-dione (MDL 18,962), an enzyme-activated inhibitor of aromatase.",
      "volume": "50",
      "author": "Johnston",
      "year": "1987",
      "journal-title": "Steroids"
    },
    {
      "key": "2019041122335472500_R75",
      "doi-asserted-by": "crossref",
      "first-page": "693",
      "DOI": "10.1016/0039-128X(81)90087-8",
      "article-title": "Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo.",
      "volume": "38",
      "author": "Brodie",
      "year": "1981",
      "journal-title": "Steroids"
    },
    {
      "key": "2019041122335472500_R76",
      "doi-asserted-by": "crossref",
      "first-page": "1684",
      "DOI": "10.1210/endo-100-6-1684",
      "article-title": "The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione, on estrogen-dependent processes in reproduction and breast cancer.",
      "volume": "100",
      "author": "Brodie",
      "year": "1977",
      "journal-title": "Endocrinology"
    },
    {
      "key": "2019041122335472500_R77",
      "first-page": "2425",
      "article-title": "Effects of aromatase inhibitors, aminoglutethimide, and 4-hydroxyandrostenedione on cyclic rats and rats with 7,12-dimethylbenz(a)anthracene-induced mammary tumors.",
      "volume": "45",
      "author": "Wing",
      "year": "1985",
      "journal-title": "Cancer Res"
    },
    {
      "issue": "Suppl",
      "key": "2019041122335472500_R78",
      "first-page": "3360s",
      "article-title": "Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.",
      "volume": "42",
      "author": "Brodie",
      "year": "1982",
      "journal-title": "Cancer Res"
    },
    {
      "key": "2019041122335472500_R79",
      "doi-asserted-by": "crossref",
      "first-page": "1237",
      "DOI": "10.1016/S0140-6736(84)92795-8",
      "article-title": "4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer.",
      "volume": "2",
      "author": "Coombes",
      "year": "1984",
      "journal-title": "Lancet"
    },
    {
      "key": "2019041122335472500_R80",
      "first-page": "4823",
      "article-title": "Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report.",
      "volume": "46",
      "author": "Goss",
      "year": "1986",
      "journal-title": "Cancer Res"
    },
    {
      "issue": "Suppl 7",
      "key": "2019041122335472500_R81",
      "first-page": "S3",
      "article-title": "Aromatase inhibition: basic concepts, and the pharmacodynamics of formestane",
      "volume": "5",
      "author": "Dowsett",
      "year": "1994",
      "journal-title": "Ann Oncol"
    },
    {
      "key": "2019041122335472500_R82",
      "doi-asserted-by": "crossref",
      "first-page": "619",
      "DOI": "10.1016/0022-4731(86)90128-7",
      "article-title": "Metabolism of the aromatase inhibitor 4-hydroxyandrostenedione in vivo. Identification of the glucuronide as a major urinary metabolite in patients and biliary metabolite in the rat.",
      "volume": "24",
      "author": "Goss",
      "year": "1986",
      "journal-title": "J Steroid Biochem"
    },
    {
      "key": "2019041122335472500_R83",
      "doi-asserted-by": "crossref",
      "first-page": "292",
      "DOI": "10.2165/00002512-199609040-00006",
      "article-title": "Formestane. A review of its pharmacological properties and clinical efficacy in the treatment of postmenopausal breast cancer.",
      "volume": "9",
      "author": "Wiseman",
      "year": "1996",
      "journal-title": "Drugs Aging"
    },
    {
      "key": "2019041122335472500_R84",
      "doi-asserted-by": "crossref",
      "first-page": "1597",
      "DOI": "10.1210/endo-108-4-1597",
      "article-title": "Enzyme-generated intermediates derived from 4-androstene-3,6,17-trione and 1,4,6-androstatriene-3,17-dione cause a time-dependent decrease in human placental aromatase activity.",
      "volume": "108",
      "author": "Covey",
      "year": "1981",
      "journal-title": "Endocrinology"
    },
    {
      "key": "2019041122335472500_R85",
      "first-page": "173",
      "article-title": "Aromatase enzyme catalysis is involved in the potent inhibition of estrogen biosynthesis caused by 4-ace.",
      "volume": "21",
      "author": "Covey",
      "year": "1982",
      "journal-title": "Mol Pharmacol"
    },
    {
      "key": "2019041122335472500_R86",
      "doi-asserted-by": "crossref",
      "first-page": "8685",
      "DOI": "10.1016/S0021-9258(18)47468-6",
      "article-title": "Potent enzyme-activated inhibition of aromatase by a 7\u03b1-substituted C19 steroid.",
      "volume": "262",
      "author": "Snider",
      "year": "1987",
      "journal-title": "J Biol Chem"
    },
    {
      "key": "2019041122335472500_R87",
      "doi-asserted-by": "crossref",
      "first-page": "533",
      "DOI": "10.1016/0022-4731(90)90170-W",
      "article-title": "7-Substituted 1,4,6-androstatriene-3,17-diones as enzyme-activated irreversible inhibitors of aromatase.",
      "volume": "36",
      "author": "Li",
      "year": "1990",
      "journal-title": "J Steroid Biochem"
    },
    {
      "key": "2019041122335472500_R88",
      "doi-asserted-by": "crossref",
      "first-page": "414",
      "DOI": "10.1016/0039-128X(93)90081-W",
      "article-title": "Synthesis and biochemical studies of 7\u03b1-substituted androsta-1,4-diene-3,17-diones as enzyme-activated irreversible inhibitors of aromatase.",
      "volume": "58",
      "author": "Ebrahimian",
      "year": "1993",
      "journal-title": "Steroids"
    },
    {
      "key": "2019041122335472500_R89",
      "doi-asserted-by": "crossref",
      "first-page": "93",
      "DOI": "10.1016/S0960-0760(96)00087-8",
      "article-title": "7\u03b1-Arylaliphatic androsta-1,4-diene-3,17-diones as enzyme-activated irreversible inhibitors of aromatase.",
      "volume": "59",
      "author": "O\u2019Reilly",
      "year": "1996",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R90",
      "doi-asserted-by": "crossref",
      "first-page": "391",
      "DOI": "10.1016/0022-4731(88)90129-X",
      "article-title": "6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): a new irreversible aromatase inhibitor.",
      "volume": "30",
      "author": "Giudici",
      "year": "1988",
      "journal-title": "J Steroid Biochem"
    },
    {
      "key": "2019041122335472500_R91",
      "doi-asserted-by": "crossref",
      "first-page": "47",
      "DOI": "10.1007/BF00258457",
      "article-title": "A new irreversible aromatase inhibitor, 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304): antitumor activity and endocrine effects in rats with DMBA-induced mammary tumors.",
      "volume": "23",
      "author": "Zaccheo",
      "year": "1989",
      "journal-title": "Cancer Chemother Pharmacol"
    },
    {
      "key": "2019041122335472500_R92",
      "doi-asserted-by": "crossref",
      "first-page": "677",
      "DOI": "10.1016/0960-0760(93)90280-A",
      "article-title": "Inhibitory effect of combined treatment with the aromatase inhibitor exemestane and tamoxifen on DMBA-induced mammary tumors in rats.",
      "volume": "44",
      "author": "Zaccheo",
      "year": "1993",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R93",
      "doi-asserted-by": "crossref",
      "first-page": "357",
      "DOI": "10.1111/j.1749-6632.1990.tb34309.x",
      "article-title": "Novel irreversible aromatase inhibitors.",
      "volume": "595",
      "author": "Di Salle",
      "year": "1990",
      "journal-title": "Ann NY Acad Sci"
    },
    {
      "key": "2019041122335472500_R94",
      "doi-asserted-by": "crossref",
      "first-page": "379",
      "DOI": "10.1016/0960-0760(90)90488-7",
      "article-title": "Biochemical and pharmacological development of steroidal inhibitors of aromatase.",
      "volume": "37",
      "author": "Brueggemeier",
      "year": "1990",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R95",
      "doi-asserted-by": "crossref",
      "first-page": "57",
      "DOI": "10.1007/BF00682741",
      "article-title": "First generation aromatase inhibitors\u2014aminoglutethimide and testololactone.",
      "volume": "30",
      "author": "Cocconi",
      "year": "1994",
      "journal-title": "Breast Cancer Res Treat"
    },
    {
      "issue": "Suppl B",
      "key": "2019041122335472500_R96",
      "doi-asserted-by": "crossref",
      "first-page": "37",
      "DOI": "10.1016/0305-7372(93)90006-D",
      "article-title": "Experience with aromatase inhibitors in the treatment of advanced breast cancer",
      "volume": "19",
      "author": "Hoffken",
      "year": "1993",
      "journal-title": "Cancer Treat Rev"
    },
    {
      "key": "2019041122335472500_R97",
      "doi-asserted-by": "crossref",
      "first-page": "241",
      "DOI": "10.1016/S0960-0760(97)80018-0",
      "article-title": "Clinical use of aromatase inhibitors in the treatment of advanced breast cancer.",
      "volume": "61",
      "author": "Trunet",
      "year": "1997",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R98",
      "doi-asserted-by": "crossref",
      "first-page": "1393",
      "DOI": "10.1021/jm00062a012",
      "article-title": "Aromatase inhibitors: synthesis, biological activity, and binding mode of azole-type compounds.",
      "volume": "36",
      "author": "Furet",
      "year": "1993",
      "journal-title": "J Med Chem"
    },
    {
      "key": "2019041122335472500_R99",
      "doi-asserted-by": "crossref",
      "first-page": "1707",
      "DOI": "10.1016/0006-2952(90)90346-M",
      "article-title": "R 76713 and enantiomers: selective, nonsteroidal inhibitors of the cytochrome P450-dependent oestrogen synthesis.",
      "volume": "40",
      "author": "Vanden Bossche",
      "year": "1990",
      "journal-title": "Biochem Pharmacol"
    },
    {
      "key": "2019041122335472500_R100",
      "doi-asserted-by": "crossref",
      "first-page": "89",
      "DOI": "10.1007/BF00682743",
      "article-title": "Vorozole, a specific non-steroidal aromatase inhibitor.",
      "volume": "30",
      "author": "Wouters",
      "year": "1994",
      "journal-title": "Breast Cancer Res Treat"
    },
    {
      "key": "2019041122335472500_R101",
      "doi-asserted-by": "crossref",
      "first-page": "103",
      "DOI": "10.1007/BF00682745",
      "article-title": "Arimidex: a potent and selective fourth-generation aromatase inhibitor.",
      "volume": "30",
      "author": "Plourde",
      "year": "1994",
      "journal-title": "Breast Cancer Res Treat"
    },
    {
      "key": "2019041122335472500_R102",
      "doi-asserted-by": "crossref",
      "first-page": "1021",
      "DOI": "10.1016/0960-0760(90)90460-3",
      "article-title": "Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor.",
      "volume": "37",
      "author": "Bhatnagar",
      "year": "1990",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R103",
      "doi-asserted-by": "crossref",
      "first-page": "95",
      "DOI": "10.1007/BF00682744",
      "article-title": "Effects of Fadrozole (CGS 16949A) and Letrozole (CGS 20267) on the inhibition of aromatase activity in breast cancer patients.",
      "volume": "30",
      "author": "Demers",
      "year": "1994",
      "journal-title": "Breast Cancer Res Treat"
    },
    {
      "issue": "Suppl 7",
      "key": "2019041122335472500_R104",
      "doi-asserted-by": "crossref",
      "first-page": "103",
      "DOI": "10.1289/ehp.95103s7103",
      "article-title": "Phytoestrogens: epidemiology and a possible role in cancer protection",
      "volume": "103",
      "author": "Adlercreutz",
      "year": "1995",
      "journal-title": "Environ Health Perspect"
    },
    {
      "key": "2019041122335472500_R105",
      "doi-asserted-by": "crossref",
      "first-page": "205",
      "DOI": "10.1016/0960-0760(94)90030-2",
      "article-title": "Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes.",
      "volume": "50",
      "author": "Wang",
      "year": "1994",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R106",
      "doi-asserted-by": "crossref",
      "first-page": "1032",
      "DOI": "10.1126/science.6474163",
      "article-title": "Inhibition of human estrogen synthetase (aromatase) by flavones.",
      "volume": "225",
      "author": "Kellis Jr",
      "year": "1984",
      "journal-title": "Science"
    },
    {
      "key": "2019041122335472500_R107",
      "doi-asserted-by": "crossref",
      "first-page": "257",
      "DOI": "10.1016/0960-0760(90)90335-I",
      "article-title": "Aromatase inhibition by flavonoids.",
      "volume": "37",
      "author": "Ibrahim",
      "year": "1990",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R108",
      "doi-asserted-by": "crossref",
      "first-page": "101",
      "DOI": "10.1016/S0304-3835(98)00211-0",
      "article-title": "Aromatase and 17\u03b2-hydroxysteroid dehydrogenase inhibition by flavonoids.",
      "volume": "133",
      "author": "Le Bail",
      "year": "1998",
      "journal-title": "Cancer Lett"
    },
    {
      "key": "2019041122335472500_R109",
      "doi-asserted-by": "crossref",
      "first-page": "751",
      "DOI": "10.1016/S0024-3205(00)00974-7",
      "article-title": "Chalcones are potent inhibitors of aromatase and 17\u03b2-hydroxysteroid dehydrogenase activities.",
      "volume": "68",
      "author": "Le Bail",
      "year": "2001",
      "journal-title": "Life Sci"
    },
    {
      "key": "2019041122335472500_R110",
      "doi-asserted-by": "crossref",
      "first-page": "85",
      "DOI": "10.1289/ehp.9810685",
      "article-title": "Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: a site-directed mutagenesis study.",
      "volume": "106",
      "author": "Kao",
      "year": "1998",
      "journal-title": "Environ Health Perspect"
    },
    {
      "key": "2019041122335472500_R111",
      "doi-asserted-by": "crossref",
      "first-page": "286",
      "DOI": "10.1023/A:1014490817731",
      "article-title": "Synthesis and aromatase inhibitory activity of flavanones.",
      "volume": "19",
      "author": "Pouget",
      "year": "2002",
      "journal-title": "Pharm Res"
    },
    {
      "key": "2019041122335472500_R112",
      "doi-asserted-by": "crossref",
      "first-page": "2859",
      "DOI": "10.1016/S0960-894X(02)00565-6",
      "article-title": "Design, synthesis and evaluation of 4-imidazolylflavans as new leads for aromatase inhibition.",
      "volume": "12",
      "author": "Pouget",
      "year": "2002",
      "journal-title": "Bioorg Med Chem Lett"
    },
    {
      "key": "2019041122335472500_R113",
      "doi-asserted-by": "crossref",
      "first-page": "672",
      "DOI": "10.1021/jm000955s",
      "article-title": "A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17\u03b1-hydroxylase/C17,20-lyase.",
      "volume": "44",
      "author": "Recanatini",
      "year": "2001",
      "journal-title": "J Med Chem"
    },
    {
      "key": "2019041122335472500_R114",
      "doi-asserted-by": "crossref",
      "first-page": "75",
      "DOI": "10.1016/S0960-0760(01)00127-3",
      "article-title": "Molecular pharmacology of aromatase and its regulation by endogenous and exogenous agents.",
      "volume": "79",
      "author": "Brueggemeier",
      "year": "2001",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R115",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1016/S0009-2797(01)00285-X",
      "article-title": "Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450.",
      "volume": "139",
      "author": "Hodek",
      "year": "2002",
      "journal-title": "Chem Biol Interact"
    },
    {
      "key": "2019041122335472500_R116",
      "doi-asserted-by": "crossref",
      "first-page": "4032",
      "DOI": "10.1021/jm0306024",
      "article-title": "Synthesis and aromatase inhibitory activity of novel pyridine-containing isoflavones.",
      "volume": "47",
      "author": "Kim",
      "year": "2004",
      "journal-title": "J Med Chem"
    },
    {
      "key": "2019041122335472500_R117",
      "doi-asserted-by": "crossref",
      "first-page": "503",
      "DOI": "10.1002/1097-0142(197402)33:2<503::AID-CNCR2820330227>3.0.CO;2-L",
      "article-title": "Proceedings: medical adrenalectomy using aminoglutethimide and dexamethasone in advanced breast cancer.",
      "volume": "33",
      "author": "Lipton",
      "year": "1974",
      "journal-title": "Cancer"
    },
    {
      "key": "2019041122335472500_R118",
      "doi-asserted-by": "crossref",
      "first-page": "2948",
      "DOI": "10.1002/1097-0142(197706)39:6<2948::AID-CNCR2820390681>3.0.CO;2-9",
      "article-title": "Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer.",
      "volume": "39",
      "author": "Santen",
      "year": "1977",
      "journal-title": "Cancer"
    },
    {
      "key": "2019041122335472500_R119",
      "doi-asserted-by": "crossref",
      "first-page": "221",
      "DOI": "10.1210/edrv-11-2-221",
      "article-title": "Endocrine treatment of breast cancer in women.",
      "volume": "11",
      "author": "Santen",
      "year": "1990",
      "journal-title": "Endocr Rev"
    },
    {
      "key": "2019041122335472500_R120",
      "doi-asserted-by": "crossref",
      "first-page": "281",
      "DOI": "10.1016/0960-0760(94)90269-0",
      "article-title": "Aromatase inhibitors in the treatment of breast cancer.",
      "volume": "49",
      "author": "Brodie",
      "year": "1994",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R121",
      "doi-asserted-by": "crossref",
      "first-page": "881",
      "DOI": "10.1200/JCO.2001.19.3.881",
      "article-title": "Aromatase inhibitors in the treatment and prevention of breast cancer.",
      "volume": "19",
      "author": "Goss",
      "year": "2001",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "2019041122335472500_R122",
      "first-page": "4392",
      "article-title": "Current status of adjuvant endocrine therapy for breast cancer.",
      "volume": "7",
      "author": "Ingle",
      "year": "2001",
      "journal-title": "Clin Cancer Res"
    },
    {
      "key": "2019041122335472500_R123",
      "first-page": "2620",
      "article-title": "Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer.",
      "volume": "7",
      "author": "Buzdar",
      "year": "2001",
      "journal-title": "Clin Cancer Res"
    },
    {
      "key": "2019041122335472500_R124",
      "doi-asserted-by": "crossref",
      "first-page": "259",
      "DOI": "10.1007/s002800100345",
      "article-title": "Role of anti-aromatase agents in postmenopausal advanced breast cancer.",
      "volume": "48",
      "author": "Murray",
      "year": "2001",
      "journal-title": "Cancer Chemother Pharmacol"
    },
    {
      "key": "2019041122335472500_R125",
      "first-page": "965",
      "article-title": "Nonsteroidal and steroidal aromatase inhibitors in breast cancer.",
      "volume": "15",
      "author": "Hamilton",
      "year": "2001",
      "journal-title": "Oncology (Huntingt)"
    },
    {
      "key": "2019041122335472500_R126",
      "doi-asserted-by": "crossref",
      "first-page": "291",
      "DOI": "10.1016/S0093-7754(01)90122-8",
      "article-title": "Endocrine therapy in the treatment of metastatic breast cancer.",
      "volume": "28",
      "author": "Buzdar",
      "year": "2001",
      "journal-title": "Semin Oncol"
    },
    {
      "key": "2019041122335472500_R127",
      "doi-asserted-by": "crossref",
      "first-page": "1286",
      "DOI": "10.1038/bjc.1996.531",
      "article-title": "Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatization and plasma oestrogen levels in postmenopausal women with breast cancer.",
      "volume": "74",
      "author": "Geisler",
      "year": "1996",
      "journal-title": "Br J Cancer"
    },
    {
      "key": "2019041122335472500_R128",
      "doi-asserted-by": "crossref",
      "first-page": "404",
      "DOI": "10.1016/0959-8049(95)00014-3",
      "article-title": "A randomized trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer",
      "volume": "32A",
      "author": "Jonat",
      "year": "1996",
      "journal-title": "Eur J Cancer"
    },
    {
      "key": "2019041122335472500_R129",
      "doi-asserted-by": "crossref",
      "first-page": "730",
      "DOI": "10.1002/(SICI)1097-0142(19970215)79:4<730::AID-CNCR10>3.0.CO;2-0",
      "article-title": "A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. Arimidex Study Group.",
      "volume": "79",
      "author": "Buzdar",
      "year": "1997",
      "journal-title": "Cancer"
    },
    {
      "key": "2019041122335472500_R130",
      "doi-asserted-by": "crossref",
      "first-page": "2000",
      "DOI": "10.1200/JCO.1996.14.7.2000",
      "article-title": "Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.",
      "volume": "14",
      "author": "Buzdar",
      "year": "1996",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "2019041122335472500_R131",
      "doi-asserted-by": "crossref",
      "first-page": "3748",
      "DOI": "10.1200/JCO.2000.18.22.3748",
      "article-title": "Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study.",
      "volume": "18",
      "author": "Bonneterre",
      "year": "2000",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "2019041122335472500_R132",
      "doi-asserted-by": "crossref",
      "first-page": "3758",
      "DOI": "10.1200/JCO.2000.18.22.3758",
      "article-title": "Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group.",
      "volume": "18",
      "author": "Nabholtz",
      "year": "2000",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "2019041122335472500_R133",
      "doi-asserted-by": "crossref",
      "first-page": "2247",
      "DOI": "10.1002/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO;2-Y",
      "article-title": "Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma.",
      "volume": "92",
      "author": "Bonneterre",
      "year": "2001",
      "journal-title": "Cancer"
    },
    {
      "key": "2019041122335472500_R134",
      "doi-asserted-by": "crossref",
      "first-page": "1286",
      "DOI": "10.1038/bjc.1996.531",
      "volume": "74",
      "author": "Geisler",
      "journal-title": "Br J Cancer"
    },
    {
      "key": "2019041122335472500_R135",
      "doi-asserted-by": "crossref",
      "first-page": "1059",
      "DOI": "10.1093/annonc/mdf083",
      "article-title": "Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism.",
      "volume": "13",
      "author": "Bajetta",
      "year": "2002",
      "journal-title": "Ann Oncol"
    },
    {
      "key": "2019041122335472500_R136",
      "first-page": "1511",
      "article-title": "In vivo measurement of aromatase inhibition by letrozole (CGS 20267) in postmenopausal patients with breast cancer.",
      "volume": "1",
      "author": "Dowsett",
      "year": "1995",
      "journal-title": "Clin Cancer Res"
    },
    {
      "key": "2019041122335472500_R137",
      "doi-asserted-by": "crossref",
      "first-page": "453",
      "DOI": "10.1200/JCO.1998.16.2.453",
      "article-title": "Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.",
      "volume": "16",
      "author": "Dombernowsky",
      "year": "1998",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "2019041122335472500_R138",
      "doi-asserted-by": "crossref",
      "first-page": "3357",
      "DOI": "10.1200/JCO.2001.19.14.3357",
      "article-title": "Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate.",
      "volume": "19",
      "author": "Buzdar",
      "year": "2001",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "2019041122335472500_R139",
      "doi-asserted-by": "crossref",
      "first-page": "208",
      "DOI": "10.1016/S0959-8049(98)00392-X",
      "article-title": "Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients.",
      "volume": "35",
      "author": "Bajetta",
      "year": "1999",
      "journal-title": "Eur J Cancer"
    },
    {
      "key": "2019041122335472500_R140",
      "doi-asserted-by": "crossref",
      "first-page": "2596",
      "DOI": "10.1200/JCO.2001.19.10.2596",
      "article-title": "Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group.",
      "volume": "19",
      "author": "Mouridsen",
      "year": "2001",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "2019041122335472500_R141",
      "doi-asserted-by": "crossref",
      "first-page": "751",
      "DOI": "10.1200/JCO.2002.20.3.751",
      "article-title": "Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study.",
      "volume": "20",
      "author": "Geisler",
      "year": "2002",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "2019041122335472500_R142",
      "first-page": "5933",
      "article-title": "Phase I and endocrine study of exemestane (FCE 24304), a new aromatase inhibitor, in postmenopausal women.",
      "volume": "52",
      "author": "Evans",
      "year": "1992",
      "journal-title": "Cancer Res"
    },
    {
      "key": "2019041122335472500_R143",
      "doi-asserted-by": "crossref",
      "first-page": "587",
      "DOI": "10.1016/S0959-8049(96)00494-7",
      "article-title": "The minimal effective exemestane dose for endocrine activity in advanced breast cancer.",
      "volume": "33",
      "author": "Bajetta",
      "year": "1997",
      "journal-title": "Eur J Cancer"
    },
    {
      "key": "2019041122335472500_R144",
      "first-page": "2089",
      "article-title": "In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients.",
      "volume": "4",
      "author": "Geisler",
      "year": "1998",
      "journal-title": "Clin Cancer Res"
    },
    {
      "key": "2019041122335472500_R145",
      "doi-asserted-by": "crossref",
      "first-page": "2234",
      "DOI": "10.1200/JCO.2000.18.11.2234",
      "article-title": "Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors: a phase II trial.",
      "volume": "18",
      "author": "Lonning",
      "year": "2000",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "2019041122335472500_R146",
      "doi-asserted-by": "crossref",
      "first-page": "1897",
      "DOI": "10.1517/13543784.9.8.1897",
      "article-title": "Pharmacology and clinical experience with exemestane.",
      "volume": "9",
      "author": "Lonning",
      "year": "2000",
      "journal-title": "Expert Opin Investig Drugs"
    },
    {
      "key": "2019041122335472500_R147",
      "first-page": "1101",
      "article-title": "Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: a phase I study.",
      "volume": "3",
      "author": "Johannessen",
      "year": "1997",
      "journal-title": "Clin Cancer Res"
    },
    {
      "key": "2019041122335472500_R148",
      "doi-asserted-by": "crossref",
      "first-page": "85",
      "DOI": "10.1016/S0960-0760(01)00126-1",
      "article-title": "Comparative clinical pharmacology and pharmacokinetic interactions of aromatase inhibitors.",
      "volume": "79",
      "author": "Boeddinghaus",
      "year": "2001",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R149",
      "doi-asserted-by": "crossref",
      "first-page": "9",
      "DOI": "10.1177/107327480200902S02",
      "article-title": "Endocrine and clinical endpoints of exemestane as neoadjuvant therapy.",
      "volume": "9",
      "author": "Miller",
      "year": "2002",
      "journal-title": "Cancer Control"
    },
    {
      "key": "2019041122335472500_R150",
      "doi-asserted-by": "crossref",
      "first-page": "317",
      "DOI": "10.1016/S0960-0760(97)00072-1",
      "article-title": "Mechanisms of the actions of aromatase inhibitors 4-hydroxyandrostenedione, fadrozole, and aminoglutethimide on aromatase in JEG-3 cell culture.",
      "volume": "63",
      "author": "Yue",
      "year": "1997",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "issue": "Suppl 1",
      "key": "2019041122335472500_R151",
      "doi-asserted-by": "crossref",
      "first-page": "S68",
      "DOI": "10.3816/CBC.2000.s.013",
      "article-title": "Comparison of in vitro exemestane activity versus other antiaromatase agents",
      "volume": "1",
      "author": "Soudon",
      "year": "2000",
      "journal-title": "Clin Breast Cancer"
    },
    {
      "issue": "Suppl 1",
      "key": "2019041122335472500_R152",
      "doi-asserted-by": "crossref",
      "first-page": "S9",
      "DOI": "10.3816/CBC.2000.s.002",
      "article-title": "Antiaromatase agents: preclinical data and neoadjuvant therapy",
      "volume": "1",
      "author": "Miller",
      "year": "2000",
      "journal-title": "Clin Breast Cancer"
    },
    {
      "key": "2019041122335472500_R153",
      "doi-asserted-by": "crossref",
      "first-page": "S17",
      "DOI": "10.1097/00000421-200308001-00004",
      "article-title": "Applicability of the intratumor aromatase preclinical model to predict clinical trial results with endocrine therapy",
      "volume": "26",
      "author": "Brodie",
      "year": "2003",
      "journal-title": "Am J Clin Oncol"
    },
    {
      "key": "2019041122335472500_R154",
      "doi-asserted-by": "crossref",
      "first-page": "1391",
      "DOI": "10.1093/annonc/mdg362",
      "article-title": "Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer.",
      "volume": "14",
      "author": "Paridaens",
      "year": "2003",
      "journal-title": "Ann Oncol"
    },
    {
      "key": "2019041122335472500_R155",
      "first-page": "28",
      "article-title": "Aromatase inhibition and antiestrogen therapy in early breast cancer treatment and chemoprevention.",
      "volume": "15",
      "author": "Ingle",
      "year": "2001",
      "journal-title": "Oncology (Huntingt)"
    },
    {
      "key": "2019041122335472500_R156",
      "doi-asserted-by": "crossref",
      "first-page": "335",
      "DOI": "10.1634/theoncologist.8-4-335",
      "article-title": "Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer.",
      "volume": "8",
      "author": "Buzdar",
      "year": "2003",
      "journal-title": "Oncologist"
    },
    {
      "key": "2019041122335472500_R157",
      "doi-asserted-by": "crossref",
      "first-page": "2131",
      "DOI": "10.1016/S0140-6736(02)09088-8",
      "article-title": "Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.",
      "volume": "359",
      "author": "Baum",
      "year": "2002",
      "journal-title": "Lancet"
    },
    {
      "key": "2019041122335472500_R158",
      "doi-asserted-by": "crossref",
      "first-page": "1802",
      "DOI": "10.1002/cncr.11745",
      "article-title": "Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses.",
      "volume": "98",
      "author": "Baum",
      "year": "2003",
      "journal-title": "Cancer"
    },
    {
      "key": "2019041122335472500_R159",
      "doi-asserted-by": "crossref",
      "first-page": "1793",
      "DOI": "10.1056/NEJMoa032312",
      "article-title": "A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.",
      "volume": "349",
      "author": "Goss",
      "year": "2003",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "2019041122335472500_R160",
      "doi-asserted-by": "crossref",
      "first-page": "1081",
      "DOI": "10.1056/NEJMoa040331",
      "article-title": "A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.",
      "volume": "350",
      "author": "Coombes",
      "year": "2004",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "2019041122335472500_R161",
      "doi-asserted-by": "crossref",
      "first-page": "619",
      "DOI": "10.1200/JCO.2005.09.121",
      "article-title": "American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.",
      "volume": "23",
      "author": "Winer",
      "year": "2005",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "2019041122335472500_R162",
      "first-page": "889",
      "article-title": "Chemoprevention of MNU-induced mammary tumorigenesis by hormone response modifiers: toremifene, RU 16117, tamoxifen, aminoglutethimide and progesterone.",
      "volume": "14",
      "author": "Moon",
      "year": "1994",
      "journal-title": "Anticancer Res"
    },
    {
      "key": "2019041122335472500_R163",
      "first-page": "1240",
      "article-title": "Antitumoral and endocrine effects of (+)-vorozole in rats bearing dimethylbenzanthracene-induced mammary tumors.",
      "volume": "52",
      "author": "De Coster",
      "year": "1992",
      "journal-title": "Cancer Res"
    },
    {
      "key": "2019041122335472500_R164",
      "doi-asserted-by": "crossref",
      "first-page": "2775",
      "DOI": "10.1093/carcin/15.12.2775",
      "article-title": "Chemopreventive effects of the aromatase inhibitors vorozole (R-83842) and 4-hydroxyandrostenedione in the methylnitrosourea (MNU)-induced mammary tumor model in Sprague-Dawley rats.",
      "volume": "15",
      "author": "Lubet",
      "year": "1994",
      "journal-title": "Carcinogenesis"
    },
    {
      "key": "2019041122335472500_R165",
      "doi-asserted-by": "crossref",
      "first-page": "633",
      "DOI": "10.1016/0960-0760(93)90270-7",
      "article-title": "Anti-tumor and endocrine effects of non-steroidal aromatase inhibitors on estrogen-dependent rat mammary tumors.",
      "volume": "44",
      "author": "Schieweck",
      "year": "1993",
      "journal-title": "J Steroid Biochem Mol Biol"
    },
    {
      "key": "2019041122335472500_R166",
      "doi-asserted-by": "crossref",
      "first-page": "487",
      "DOI": "10.1016/S0960-0760(03)00378-9",
      "article-title": "Breast cancer prevention\u2014clinical trials strategies involving aromatase inhibitors.",
      "volume": "86",
      "author": "Goss",
      "year": "2003",
      "journal-title": "J Steroid Biochem Mol Biol"
    }
  ],
  "container-title": "Endocrine Reviews",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "http://academic.oup.com/edrv/article-pdf/26/3/331/8861344/edrv0331.pdf",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2021,
        7,
        11
      ]
    ],
    "date-time": "2021-07-11T00:47:58Z",
    "timestamp": 1625964478000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://academic.oup.com/edrv/article/26/3/331/2355224"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2005,
        4,
        6
      ]
    ]
  },
  "references-count": 166,
  "journal-issue": {
    "issue": "3",
    "published-online": {
      "date-parts": [
        [
          2005,
          4,
          6
        ]
      ]
    },
    "published-print": {
      "date-parts": [
        [
          2005,
          5,
          1
        ]
      ]
    }
  },
  "URL": "http://dx.doi.org/10.1210/er.2004-0015",
  "relation": {},
  "ISSN": [
    "0163-769X",
    "1945-7189"
  ],
  "subject": [],
  "published": {
    "date-parts": [
      [
        2005,
        4,
        6
      ]
    ]
  }
}